Japan is set to implement its latest annual drug reimbursement price revision under the national health insurance scheme, which the Ministry of Health, Labour and Welfare (MHLW) estimates will cut annual national healthcare costs by JPY310bn ($2.3bn).
The new prices, announced by the ministry in March, will be effective from 1 April, and an analysis of the...






